We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Intuitive Investments Group Plc | LSE:IIG | London | Ordinary Share | GB00BPTH6Y20 | ORD GBP0.1 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 127.50 | 120.00 | 135.00 | 127.50 | 127.50 | 127.50 | 12,581 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investors, Nec | -2.45M | -3.24M | -0.0161 | -79.19 | 256.58M |
TIDMIIG
RNS Number : 3950M
Intuitive Investments Group plc
11 January 2023
11 January 2023
Intuitive Investments Group plc
Investment in Yourgene Health plc
Intuitive Investments Group plc (AIM: IIG) ("IIG" or the "Company"), a closed-end investment company focussed on the life sciences sector, has invested GBP150,407 to acquire 50 million ordinary shares of Yourgene Health plc (AIM: YGEN) ("Yourgene") at a price of 0.3 pence per share. IIG holds 51,584,920 ordinary shares of Yourgene in total.
Julian Baines, Chairman of IIG and Robert Naylor, CEO of IIG, have holdings of 5,000,000 ordinary shares and 33,497,789 ordinary shares in Yourgene respectively .
For further information, please contact:
Intuitive Investments Group plc www.iigplc.com Julian Baines, Chairman Via Walbrook PR Robert Naylor, CEO SP Angel Corporate Finance LLP - Nominated Adviser +44 (0) 20 3470 0470 Jeff Keating / David Hignell / Kasia Brzozowska Turner Pope Investments (TPI) Ltd - Broker +44 (0) 20 3657 0050 Andrew Thacker / James Pope Walbrook PR Limited - Media & +44 (0)20 7933 8780 or intuitive@walbrookpr.com Investor Relations +44 (0) 7980 541 893 / +44 (0) Paul McManus / Sam Allen 7502 558 258
About Intuitive Investments Group plc
Intuitive Investments Group plc is an investment company seeking to provide investors with exposure to a portfolio concentrating on fast growing and/or high potential Life Sciences businesses operating predominantly in the UK, continental Europe and the US, utilising the Board's experience and in particular that of the Chairman of the Investment Committee, David Evans, to seek to generate capital growth over the long term for shareholders
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCSFLSUFEDSELF
(END) Dow Jones Newswires
January 11, 2023 05:00 ET (10:00 GMT)
1 Year Intuitive Investments Chart |
1 Month Intuitive Investments Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions